Population standards of prostate specific antigen values in men over 40: Community based study in Turkey

被引：10
作者：
Müezzinoǧlu T. [1 ]
Lekili M. [1 ]
Eser E. [2 ]
Uyanik B.S. [3 ]
Büyüksu C. [1 ]
机构：
[1] Department of Urology, School of Medicine, Celal Bayar University
[2] Department of Health Sciences, School of Medicine, Celal Bayar University
[3] Department of Biochemistry, School of Medicine, Celal Bayar University
来源：
International Urology and Nephrology | 2005年 / 37卷 / 2期
关键词：
Age-specific; Normal values; Population; Prostate carcinoma; PSA;
D O I：
10.1007/s11255-004-7976-y
中图分类号：
学科分类号：
摘要：
Objective: To determine the prostate specific antigen (PSA) population standards of a cluster of Turkish men with no clinical evidence of prostate cancer. Patients and methods: We evaluated PSA values of the men who were living in a well-defined, rural district of Western Anatolia. Two hundred fifty-seven men agreed to participate in this population-based study. They underwent clinical examination, transrectal ultrasonography and serum PSA measurement. The association between serum PSA and age, prostate volume and age, PSA and prostate volume, and PSA density (PSAD) and age were assessed. Distributions of serum PSA levels, prostate volumes (PV), and PSAD values as a function of age were generated. Results: The upper limit of normal PSA concentration were 4.51 ng/ml for men aged 40-49 years, 4.36 ng/ml for 50-59 years, 6.17 ng/ml for 60-69 years, and 10.18 ng/ml for over 70 years. The upper limit of normal (95th percentile) for the serum PSA concentration increased with age. Across the entire age range, no correlation was found between the serum PSA concentrations and age while significant correlation was found between serum PSA concentration and prostate volume. Conclusion: In this present study, the PSA values in different age intervals showed higher than those observed in previous studies. The PSA values are mainly affected by prostate volume rather than age. © Springer 2005.
引用
收藏
页码：299 / 304
页数：5
相关论文
共 15 条
  • [1] Brawer M.K., Prostatic intraepithelial neoplasia and prostate specific antigen, Urology, 34, 6 SUPPL., pp. 62-65, (1989)
  • [2] Oesterling J.E., Jacobsen S.J., Chute C.G., Et al., Serum prostate specific antigen in a community-based population of healthy men: Establishment of age-specific reference ranges, JAMA, 270, pp. 860-864, (1993)
  • [3] Babaian R.J., Miyashita H., Evans R.B., Et al., The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: Relationship to gland volume and age, J. Urol., 147, PART 2, pp. 837-840, (1992)
  • [4] Oesterling J.E., Kumamoto Y., Tsukamoto T., Et al., Serum prostate-specific antigen in a community-based population of healthy Japanese men: Lower values than for similarly aged white men, Brit. J. Urol., 75, pp. 347-353, (1995)
  • [5] Collins G.N., Lee R.J., Mckelvie G.B., Et al., Relationship between prostate specific antigen, prostatic volume and age in the benign prostate, Br. J. Urol., 71, pp. 445-450, (1993)
  • [6] Dalkin B.L., Ahmann F.R., Kopp J.B., Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma, J. Urol., 150, pp. 1837-1839, (1993)
  • [7] Akduman B., Alkibay T., Tuncel A., Bozkyrly I., The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men, The Canadian Journal of Urology, 7, 5, pp. 1104-1109, (2000)
  • [8] Brawer M.K., Chetner M.P., Beatie J., Et al., Screening for prostatic carcinoma with prostate specific antigen, J. Urol., 147, pp. 841-845, (1991)
  • [9] Babaian R.J., Fritsche H.A., Evans R.B., Prostate-specific antigen and prostate gland volume: Correlation and clinical application, J. Clin. Lab. Anal., 4, 2, pp. 135-137, (1990)
  • [10] Rhodes T., Girman C.J., Jacobsen S.J., Et al., Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old, J. Urol., 161, 4, pp. 1174-1179, (1999)
12